Telomir Pharmaceuticals, Inc. (TELO) Return on equity
Telomir Pharmaceuticals, Inc. (TELO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to TELOSource: SEC XBRL filings · For reference only · Not investment advice
More TELO financial trends
TELO RevenueTELO Net incomeTELO Net marginTELO Gross profitTELO Gross marginTELO Operating incomeTELO Operating marginTELO Operating cash flowTELO Free cash flowTELO Capital expendituresTELO Stock buybacksTELO Dividends paidTELO Total assetsTELO Total liabilitiesTELO Shareholders’ equityTELO overview →